首頁 › 套細胞淋巴瘤 › 田納西州 › Nashville
Nashville, TN 的 套細胞淋巴瘤 臨床試驗
11 項針對 套細胞淋巴瘤 的研究正在 Nashville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- Tennessee Oncology, Pllc Nashville, Nashville
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
招募中2 期
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
招募中3 期
- Tennessee Oncology Nashville St Thomas Midtown Clinic, Nashville
- Tennessee Oncology, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- SCRI Oncology Partners, Nashville
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
招募中2 期
- Vanderbilt University/Ingram Cancer Center, Nashville
Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
招募中2 期
- Vanderbilt University/Ingram Cancer Center, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- TriStar BMT, Nashville
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
招募中1 期
- Tennessee Oncology, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- SCRI Oncology Partners, Nashville
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Tennessee Oncology, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Nashville
其他城市的 套細胞淋巴瘤 試驗
- Houston, TX15 項研究
- Baldwin Park, CA15 項研究
- Durham, NC13 項研究
- Seattle, WA12 項研究
- New York City, NY12 項研究
- Milwaukee, WI12 項研究
- Boston, MA11 項研究
- Columbus, OH11 項研究
- Chicago, IL10 項研究
- Rochester, MN9 項研究
- Portland, OR9 項研究
- St. Louis, MO8 項研究
Nashville 的其他研究
- 非小細胞肺癌97 項研究
- 乳癌81 項研究
- 轉移性癌症70 項研究
- 大腸直腸癌69 項研究
- 癌症（所有類型）65 項研究
- 卵巢癌49 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 頭頸部鱗狀細胞癌39 項研究
- 胰臟癌39 項研究
- 子宮內膜癌38 項研究
- 黑色素瘤33 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。